N-terminal pro-B-type natriuretic peptide in atrial fibrillation: time to look beyond clinical risk scores, or not?

Salmon T, McDowell G, Lip GYH

Open source

DOI
10.1136/heartjnl-2026-328868
Published
2026 Sep 18
Container
Heart (British Cardiac Society)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/heartjnl-2026-328868,
  title = {N-terminal pro-B-type natriuretic peptide in atrial fibrillation: time to look beyond clinical risk scores, or not?},
  author = {Salmon T and McDowell G and Lip GYH},
  year = {2026},
  journal = {Heart (British Cardiac Society)},
  doi = {10.1136/heartjnl-2026-328868},
  url = {https://doi.org/10.1136/heartjnl-2026-328868}
}

RIS

TY  - JOUR
TI  - N-terminal pro-B-type natriuretic peptide in atrial fibrillation: time to look beyond clinical risk scores, or not?
AU  - Salmon T
AU  - McDowell G
AU  - Lip GYH
PY  - 2026
JO  - Heart (British Cardiac Society)
DO  - 10.1136/heartjnl-2026-328868
UR  - https://doi.org/10.1136/heartjnl-2026-328868
ER  - 

APA

T, S., G, M., & GYH, L. (2026). N-terminal pro-B-type natriuretic peptide in atrial fibrillation: time to look beyond clinical risk scores, or not?. Heart (British Cardiac Society). https://doi.org/10.1136/heartjnl-2026-328868

Source records